Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3846498

Cc1cccc(N2CCN(c3ccnc4ccc(-c5cn[nH]c5)cc34)CC2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.46
MAPKAPK2 P49137 2/20 0.42
MTOR P42345 3/20 0.38
BLK P51451 1/20 0.38
BMX P51813 1/20 0.38
JAK3 P52333 1/20 0.38
BTK Q06187 1/20 0.38
AKT1 P31749 1/20 0.38
DYRK1A Q13627 3/20 0.38
GSK3B P49841 1/20 0.38
C1S P09871 1/20 0.38
ALK Q9UM73 1/20 0.38
PIK3CA P42336 2/20 0.37
GRK2 P25098 1/20 0.37
GRK5 P34947 1/20 0.37
GRK1 Q15835 1/20 0.37
DHFR P00374 1/20 0.37
PIM1 P11309 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3852308 0.91 GRK2 (0.46) MAPKAPK2AKT1GRK2GRK5
Trifluoroacetic Acid SCHEMBL3846847 0.91 MAPKAPK2 (0.44) MAPKAPK2MTORBLKBMXJAK3
Trifluoroacetic Acid SCHEMBL5852101 0.89 MLYCD (0.42) PIK3CA
Trifluoroacetic Acid SCHEMBL4717163 0.87 CYP3A4 (0.40) MTORBLKBMXJAK3BTK
Trifluoroacetic Acid SCHEMBL4711647 0.87 HTR1A (0.38) MTORBLKBMXJAK3BTK
Trifluoroacetic Acid SCHEMBL3849021 0.86 AKT1 (0.52) AKT1
Trifluoroacetic Acid SCHEMBL3845912 0.86 NCF1 (0.45) MAPKAPK2MTORAKT1DYRK1AGSK3B
Trifluoroacetic Acid SCHEMBL3848126 0.84 KCNH2 (0.44) KCNH2MAPKAPK2MTORC1SDHFR
Trifluoroacetic Acid SCHEMBL3846732 0.84 PIK3CA (0.40) MAPKAPK2MTORBLKBMXJAK3
SCHEMBL30734137 0.82 KCNH2 (0.48) KCNH2MAPKAPK2DYRK1AALKGRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed